IMMUNIC, INC. Shares of Common Stock ($0.0001 par value per share) SALES AGREEMENTSales Agreement • January 4th, 2021 • Immunic, Inc. • Pharmaceutical preparations • New York
IMMUNIC, INC., a Delaware corporation (the “Company”), has previously entered into a Sales Agreement with SVB Leerink LLC (the “Agent”) dated as of July 17, 2019 (the “2019 Sales Agreement”) to issue and sell shares of common stock, $0.0001 par value per share, of the Company (the “Common Stock”) pursuant to a registration statement filed by the Company on Form S-3 on May 25, 2018, as amended on June 8, 2018 (File No. 333-225230) (the “2018 S-3”), which 2019 Sales Agreement remains in full force and effect on the date hereof. The Company now confirms a subsequent agreement (the “Agreement”) with the Agent, as follows:
